Glucagon-Like Peptide-1 Receptor Agonists-How Safe Are They?

JAMA Intern Med · 2022

Last updated 2026-05-28

Journal	JAMA Intern Med, 2022
Citations	6
Relative citation ratio	0.51
NIH percentile	29
Molecules	—
Conditions studied	Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash, Obstructive Sleep Apnea, Pcos, Heart Failure

Full record and abstract on PubMed 35344015 ↗